April 21, 2017 — Lifetrack Medical Systems Inc. announced U.S. Food and Drug Administration (FDA) approval of its Lifesys PACS (picture archiving and communication system), a fourth-generation PACS enabling truly distributed radiology for better healthcare.
Already deployed in Southeast Asia and South Asia, Lifetrack's patented platform is extending the reach of high-quality medicine by greatly simplifying and speeding deployment of digital radiology, all while significantly reducing costs, and solving the challenges of bringing high-quality diagnostic reporting to large underserved populations.
The Lifesys platform features unique and patented RadNav technology, which serves a guidance system to radiologists through its integrated decision support system and active templates.
Customers of the Lifesys platform report that they are able to produce comprehensive and accurate reports consistently with turnaround times under 15 minutes, even on complex cases. Patients benefit from better more comprehensive reports leading to more rapid and effective treatment.
For more information: www.lifetrackmed.com
March 10, 2026 
